REGENERON PHARMACEUTICALS shareholders Q3 2023

REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 10 filers reported holding REGENERON PHARMACEUTICALS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

REGENERON PHARMACEUTICALS shareholders Q3 2023
NameSharesValueWeighting ↓
Garda Capital Partners LP 3,500$2,880,3600.13%
Allianz Asset Management GmbH 31,500$25,923,2400.04%
SIMPLEX TRADING, LLC 64,400$52,9980.04%
JANE STREET GROUP, LLC 47,900$39,419,7840.01%
IMC-Chicago, LLC 16,500$13,578,8400.01%
GROUP ONE TRADING, L.P. 2,600$2,139,6960.01%
SG Americas Securities, LLC 23,600$3160.00%
Maven Securities LTD 400$329,1840.00%
JPMORGAN CHASE & CO 26,500$21,808,4400.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%

This page lists REGENERON PHARMACEUTICALS's shareholders in Q3 2023. To view REGENERON PHARMACEUTICALS's shareholder history, click here.